Several case series (56) and open-label trials (5760) suggest that the combination of a better glycemic control, improved metabolic parameters and bodyweight reductions achieved by exenatide treatment as monotherapy or as add-on to standard therapies may lead to improvements in liver biomarkers and hepatic fat reductions in patients with T2D
As a result, some doctors may recommend GLP-1 drugs to help manage both blood sugar levels and weight in people with lupus
Multiple sclerosis progression: time for a new mechanism-driven framework
Zheng S, Huang H, Chen H, Liu Y
Selenium yeast can effectively alleviate oxidative damage by regulating different signal pathways, improving the activity of antioxidant enzymes, reversing the content of inflammatory factors, regulating the protein expression of apoptosis-related genes, and reducing the accumulation of mycotoxins and heavy metals in the body